GridAI Technologies (GRDX) Debt Ratio (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Debt Ratio came in at 0.13 in Q4 2025, up 2389.43% on a QoQ basis from 0.01 in Q3 2025.

GridAI Technologies (GRDX) Debt Ratio (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 8 years of Debt Ratio data on file, last reported at 0.13 in Q4 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.13 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.13 (changed N/A YoY) and the FY2025 annual result came in at 0.13, changed N/A from the prior year.
Debt Ratio grew to 0.13 in Q4 2025, from 0.01 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.13 in Q4 2025 to a low of 0.01 in Q3 2025.
A 3-year average of 0.04 and a median of 0.01 in 2021 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2021 — Debt Ratio plunged 43.51% — and 2025, when it sank 88.3%.
Tracing GRDX's Debt Ratio over 3 years: stood at 0.02 in 2021, then jumped by 263.73% to 0.07 in 2024, then soared by 83.37% to 0.13 in 2025.
The last three Debt Ratio figures came in at 0.13 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	GridAI Technologies	5.82 Mn	5.82 Mn	-	0.13

Download Data